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Systemic lupus erythematosus (SLE) is a chronic 
autoimmune disease characterized by the pro-
duction of autoantibodies against a wide spec-
trum of self-antigens, especially from the cell 
nucleus. Genes in multiple pathways participate 
in mediating disease pathogenesis, and epistatic 
interactions among these genes influence the 
severity of disease. SLE-related genes include, 
for instance, those involved in physiological 
pathways of waste disposal mechanisms, regu-
lating the removal of circulating immune com-
plexes and apoptotic cells by the mononuclear 
phagocyte system, or those involved in T cell 
functions. Several of the signaling lymphocytic 
activation molecule (SLAM) family (SLAMF) 
genes, which encode cell surface receptors and 
which affect both antigen-presenting cell and   
T cell functions, may also regulate thresholds for 
tolerance and activation of T and B lymphocytes 
as  well  as  reactivation-induced  cell  death 
(Wandstrat et al., 2004; Kumar et al., 2006;   
Carlucci  et  al.,  2007;  Calpe  et  al.,  2008;   
Cunninghame Graham et al., 2008; Snow et al., 
2009;  Detre  et  al.,  2010;  Kim  et  al.,  2010;   
Morel, 2010; You et al., 2010).
In mice, the SLAMF cell surface receptors 
encode nine genes (Slamf1–9; Calpe et al., 2008) 
that vary between two sets of mouse strains: 
Slamf-haplotype  1,  e.g.,  C57BL/6  (B6),  and 
Slamf-haplotype 2, e.g., NZW or 129 (Wandstrat 
et al., 2004; Detre et al., 2010). In the lupus-
prone congenic mouse strains, B6.Sle1b (Sle1b) 
and B6.129chr1b, DNA segments derived from 
NZW or 129, respectively, are embedded in 
the  B6  genome. These  NZW  or  129  seg-
ments contain several genes, including Slamf1–7. 
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Studies of human systemic lupus erythematosus patients and of murine congenic mouse 
strains associate genes in a DNA segment on chromosome 1 with a genetic predisposition 
for this disease. The systematic analysis of lupus-prone congenic mouse strains suggests a 
role for two isoforms of the Ly108 receptor in the pathogenesis of the disease. In this 
study, we demonstrate that Ly108 is involved in the pathogenesis of lupus-related auto-
immunity in mice. More importantly, we identified a third protein isoform, Ly108-H1, 
which is absent in two lupus-prone congenic animals. Introduction of an Ly108-H1–
expressing transgene markedly diminishes T cell–dependent autoimmunity in congenic 
B6.Sle1b mice. Thus, an immune response–suppressing isoform of Ly108 can regulate the 
pathogenesis of lupus.
© 2011 Keszei et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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T cell–dependent autoimmune disease (Crispín et al., 2010b), 
the percentage of effector/memory CD4+ T cells was in-
creased in aged B6.129chr1b and Sle1b mice (Fig. 1 B).   
In contrast, the percentage of effector/memory CD4+ T cells 
Autoantibodies develop because of an epistatic interplay be-
tween one or more Slamf-haplotype 2 genes with B6 genes 
(Bygrave et al., 2004; Wandstrat et al., 2004; Carlucci et al., 
2007). Based on the studies with the Sle1b mouse (Wandstrat 
et al., 2004; Kumar et al., 2006), Ly108 (Slamf6) has been sug-
gested as a candidate susceptibility gene for SLE. An initial 
study using BALB/c splenocytes identified two Ly108-coding 
cDNAs (Peck and Ruley, 2000), later termed Ly108-1 (Gen-
Bank/EMBL/DDBJ accession no. AF248635.1) and Ly108-2 
(GenBank accession no. AF248636.1). These two splice vari-
ants of Ly108 are thought to encode protein isoforms with 
identical extracellular domains but differing cytoplasmic tails. 
The ratio of transcripts encoding Ly108-1 and Ly108-2 dif-
fers in Sle1b and B6 lymphocytes, which is thought to influ-
ence early B cell development (Kumar et al., 2006), resulting 
in increased autoantibody production. The B cell experiments 
led to the conclusion that “the normal Ly108-2 allele, but not 
the lupus-associated Ly108-1 allele, was found to sensitize 
immature B cells to deletion and RAG re-expression” (Kumar 
et al., 2006).
In this study, we use gene-targeted mutant and congenic 
mice in combination with bacterial artificial chromosome 
(BAC)–based transgenic mice to provide evidence that Ly108 
is involved in the regulation of SLE in a CD4+ T cell–dependent 
manner. In addition to Ly108-1 and Ly108-2, we identify a 
novel protein isoform, Ly108-H1, which is present only in 
Slamf-haplotype 1 mice and not in the lupus-prone Sle1b or 
B6.129chr1b strains. Introduction of one copy of an Ly108-
H1 BAC-based transgene into the Sle1b dramatically reduces 
lupus-related autoimmunity. Thus, although the Slamf-haplo-
type 2 segment in the congenic Sle1b mouse contains circa 
20 genes, the Ly108-H1 isoform plays a dominant role in 
suppressing the pathogenesis of SLE.
RESULTS
The congenic Ly108/ [129 × B6] mouse does not develop 
SLE, in contrast to the B6.129chr1b congenic mouse, which 
contains the same 129-derived segment
To examine whether disruption of the Ly108 gene would   
affect the development of murine lupus, we backcrossed our 
congenic Ly108/ [129 × B6] mouse, which was generated 
with 129-derived embryonic stem (ES) cells (Howie et al., 
2005), with the WT B6 mouse. In addition, we generated a 
new B6.Ly108/ mouse using B6 ES cells (Fig. S1, A–D). 
We hypothesized that the congenic Ly108/ [129 × B6] 
mouse would not develop lupus if Ly108 played a dominant 
role in the pathogenesis of the disease. In contrast, Ly108/ 
[129 × B6] would develop disease if genes other than Ly108 
that are present in the selected 129-derived segment were of 
equal or greater importance.
We found that in aged Ly108/ [129 × B6] females, anti-
nucleosome autoantibody levels were similar to those in B6 
mice, whereas these antibodies were detected in the serum of 
the lupus-prone B6.129chr1b [129 × B6] and Sle1b [NZW × 
B6] mice. Furthermore, the B6.Ly108/ mice also did 
not develop lupus (Fig. 1 A). As expected in the case of a   
Figure 1.  The Ly108/ [129 × B6] mouse does not develop SLE, 
in contrast to the B6.129chr1b congenic mouse, which contains a 
similar 129-derived segment. (A) Antinucleosome antibodies in the 
serum of individual females (10–13 mo old) were determined, as indicated 
in Materials and methods. Mice were aged in the same animal facility, and 
sera were collected and stored at 80°C until analysis. Sle1b, n = 10; 
B6.129chr1b, n = 6; Ly108/ [129 × B6], n = 14; B6, n = 38; Ly108/ 
[B6], n = 13. Mean titers are indicated by a horizontal line. EU, ELISA units. 
(B) Percentage of effector/memory CD4+ cells was determined by flow 
cytometric analysis of the spleen of individual females (10–13 mo old) as 
described in Materials and methods. Sle1b, n = 6; B6.129chr1b, n = 6; 
Ly108/ [129 × B6], n = 12; B6, n = 25. Mean values are indicated by a 
horizontal line. (C) Congenic boundaries of the 129 segments on chromo-
some 1 of Ly108/ [129 × B6] and of B6.129chr1b mice were determined 
using the Mouse Diversity Genotyping array (Affymetrix) and microsatel-
lite analysis. (D) Normal T cell–dependent humoral response in Ly108/ 
[129 × B6] mice. Ly108/ [129 × B6] and WT [B6] mice were immunized 
i.p. with 50 µg NP-KLH, and 14 d after immunization, serum titers were 
determined by ELISA using NP(23)-BSA–coated plates. The mean values 
and SDs of NP-specific IgG titers were determined using five mice/group. 
All statistical analyses in this figure were performed by the Mann- 
Whitney nonparametric, two-tailed test.JEM VOL. 208, April 11, 2011 
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T cell–dependent low- and high-affinity antibody responses 
to haptenated proteins by the congenic Ly108/ [129 × B6] 
mice are identical to those by WT B6 mice. We conclude that 
the absence of the lupus-susceptibility gene Ly108 signifi-
cantly reduces antinucleosome antibody responses and CD4+ 
T cell expansion in a B6 mouse, which contains a short 129-
derived segment.
Protein isoform analysis detects Ly108-H1, a novel protein 
isoform, which is coexpressed with Ly108-1 and Ly108-2  
in Slamf-haplotype 1 mice
Because the difference in expression levels of the two Ly108 
alleles in the Sle1b and B6 mouse was based on quantitative 
PCR (Wandstrat et al., 2004), we set out to examine whether 
the Ly108-1/2 isoform variability was reflected at the protein 
level of Slamf-haplotype 1 and 2 mice. First, we assessed the 
expression pattern of Ly108 on the surface of hematopoietic 
cells derived from known Slamf-haplotype 1 and 2 mice using 
our anti-Ly108 monoclonal antibody, 13G3, which is specific 
for the extracellular region of the receptor (Fig. 2 A). Surpris-
ingly, CD48 (double negative) and CD4+8+ (double posi-
tive) thymocyte subsets derived from the Slamf-haplotype 1 
mice, B6 and MOLF/EiJ, expressed considerably more Ly108 
than thymocyte subsets isolated from Slamf-haplotype 2 mice, 
e.g., BALB/c, 129, and Sle1b (Fig. 2 A).
The difference in Ly108 cell surface expression in Slamf-
haplotype 1 mice appeared to be a reflection of increased 
transcription of the Slamf6 gene, as judged by quantitative 
PCR (Fig. S2). We therefore evaluated whether the difference 
in cell surface expression among strains of the two Slamf-
haplotypes could be attributed to an increase in Ly108 protein 
expression, particularly among the two isoforms. To this end, 
immunoprecipitates made with monoclonal -Ly108 (13G3) 
were  subjected  to  SDS-PAGE,  and  the  protein  isoforms 
Ly108-1 and Ly108-2 were identified by Western blotting with 
two  polyclonal  antibodies.  One  antibody  (R4)  was  directed 
in the aged Ly108/ [129 × B6] mice was equivalent to that 
in WT  B6  mice  (Fig.  1  B).  Low-resolution  microsatellite 
marker analysis of the boundaries of the 129-derived segment 
in Ly108/ [129 × B6] and B6.129chr1b mice showed that 
they were similar (Fig. 1 C and Fig. S1 F). Support for the 
presence of the 129-derived segment (e.g., Slamf-haplotype 2) 
in both mouse strains comes from staining with haplotype 2–
specific -Hap2 antibody (Fig. S1 E). To fine-map the exact 
breakpoint between the B6 genetic background and the 129 
congenic insert in Ly108/ [129 × B6] and B6.129chr1b 
mice, we used a single nucleotide polymorphism (SNP) ge-
notyping microarray. Notably, on the centromeric side of the 
congenic insert, the first 129 SNP allele was rs32120942 
(National Center for Biotechnology Information [NCBI] SNP 
database accession no.) for both the Ly108/ [129 × B6] and 
B6.129chr1b analysis (Fig. 1 C and Table S2). However, the 
exact breakpoint upstream of SNP rs32120942, which spans 
4.8 Mb, could not be determined as no sequence differences 
among the 1,406 B6 and 129 SNP alleles were included on 
the array. This observation argues that the centromeric side 
recombinant region belongs to an identical large haplotype 
block in 129 and B6 mice; thus, there is no reason to attempt 
to find the exact breakpoint. On the telomeric side, the 129-
derived segment is 2 Mb longer in Ly108/ [129 × B6] than 
in B6.129chr1b and contains 18 RefSeq genes (Fig. S1 G). 
None of the possible differences between Ly108/ [129 × 
B6] and B6.129chr1b genomic sequence overlap with any of 
the described SLE suppressor regions in 129 or NZW (Morel 
et al., 1999; Subramanian et al., 2005). Thus, the disruption of 
the  Ly108  gene  in  a  congenic  mouse  ameliorates  disease 
found in a very similar congenic mouse strain that harbors the 
intact 129-derived Ly108 gene.
Because the homophilic receptor Ly108 is expressed on 
both T and B cells, we examined whether specific T cell–
dependent  antibody  responses  would  be  affected  by  the 
Ly108null mutation. As shown in Fig. 1 D and Fig. S1 H,   
Figure 2.  Ly108-H1, a novel protein 
isoform, is only expressed in Slamf- 
haplotype 1 mice. (A) Ly108 cell surface 
expression in Slamf-haplotype 1 and 2 T lin-
eage cells was determined by flow cytometric 
analysis. The mean fluorescence intensity 
(MFI) is given as a mean of three animals in 
each group. Results are representative of four 
independent experiments. DN, double nega-
tive thymocytes; DP, double positive thymo-
cytes. (B) Protein expression of Ly108 in 
lysates of thymocytes or splenic CD4+ T cells 
isolated from B6 and BALB/c mice. Anti-Ly108 
immunoprecipitates were subjected to SDS-PAGE, and proteins were detected by Western blotting (WB) using either polyclonal antibody R1, which recog-
nizes the cytoplasmic tails of both Ly108-1 and Ly108-2, or polyclonal antibody R4, which is directed against a peptide that is only present in the cyto-
plasmic tail of Ly108-2 (see also Fig. 3 D). The data are representative of two independent experiments. (C) Immunoprecipitates (IP: -Ly108) from B6 and 
129 thymocytes were deglycosylated with PNGaseF before SDS-PAGE followed by Western blotting using R1 (top) and R4 (bottom) antibodies. The data 
are representative of two independent experiments. (D) Lysates of B cells isolated from the spleen of B6, 129, BALB/c, and NOD mice by magnetic cell 
sorting were immunoprecipitated with anti-Ly108 and were subjected to PNGaseF treatment, SDS-PAGE, and Western blotting with R1 or R4. The figure 
shows a single analysis of four different mouse strains.814 Novel isoform of Ly108 protects against lupus | Keszei et al.
tation by Western blotting of immunoprecipitates is inher-
ently difficult, a difference in protein expression of Ly108-1 
and Ly108-2 could not be excluded.
The Ly108-H1 protein is encoded by a splice variant  
of Ly108 that lacks both exons 7 and 8
The detection of Ly108-H1 by R4 but not by R1, which was 
raised against a peptide sequence encoded by exon 7, sug-
gested that the R1 peptide sequence, containing the second 
immuno-tyrosine switch motif (ITSM), was absent from 
Ly108-H1 (Fig. 3 D). Based on the protein analyses, we tested 
the possibility that lymphocytes from Slamf-haplotype 1 mice 
expressed an Ly108 splice variant lacking sequences for exons 
7 and 8. Using exon 1– and exon 9–specific primer pairs, two 
PCR  products,  presumably  Ly108-2  and  Ly108-H1,  were 
amplified from B6 thymocytes (Fig. 3 A). Subsequent cloning 
and sequence analysis of the cDNAs confirmed that B6 thy-
mocytes indeed express a transcript that lacks both exons 7 
and 8 (GenBank/EMBL/DDBJ accession no. ACF05482).
To  determine  whether  this  novel  transcript  encodes 
Ly108-H1, three cDNAs were transiently transfected into the 
Ly108-negative T cell line BI-141 (Fig. 3 B). Immunoprecipi-
tation  followed  by  deglycosylation  with  PNGaseF,  SDS-
PAGE, and immunoblotting verified that Ly108- exon 7/8 
cDNA encoded the Ly108-H1 protein, as judged by its 
against a unique amino acid sequence in the C terminus of 
the Ly108-2 cytoplasmic tail and the second antibody (R1) 
against a cytoplasmic tail segment shared by the two isoforms 
(Fig. 3 D). The glycosylated Ly108-1 and Ly108-2 proteins, 
when precipitated from thymocytes and CD4+ T cells of B6 
or BALB/c mice, ran as indistinguishable bands upon Western 
blotting with R1. However, when the immunoprecipitates 
were blotted with the R4 antibody, samples from B6 mice 
consistently showed higher Ly108-2 expression as compared 
with the same cell subsets of the BALB/c animals (Fig. 2 B). 
Upon deglycosylation with the enzyme PNGaseF (peptide: 
N-glycosidase F), Ly108-1 and Ly108-2 protein isoforms mi-
grated according to their predicted molecular masses, 34 kD 
and 36 kD, respectively (Fig. 2 C, top). Surprisingly, when the 
membranes were reprobed with the R4 antibody (Fig. 2 C, 
bottom), two proteins were detected in B6 thymocytes. In 
addition to the 36-kD Ly108-2 protein, a smaller 30-kD 
protein,  designated  Ly108-H1,  was  present  only  in  the   
B6 thymocytes. The Ly108-H1 protein was also present in 
B lymphocytes of B6 mice but not in 129, BALB/c, or NOD 
B lymphocytes (Fig. 2 D).
Thus, the presence of a previously unidentified protein 
isoform, Ly108-H1, expressed exclusively in Slamf-haplotype 1 
mouse strains, could, at least in part, have accounted for the 
elevated Ly108 expression in B6 thymocytes. Because quanti-
Figure 3.  The Ly108-H1 protein is encoded by a splice variant of Ly108 that lacks both exons 7 and 8. (A, left) Diagram of the nine exons of 
the Ly108 gene. Both exons 8 and 9 contain a 3 untranslated region. Location of the exon 1–9 primers is indicated with red arrowheads. (right) RT-PCR 
using mRNA from B6, 129, BALB/c, and NOD thymocytes. (B) Ly108 cell surface expression on CD4+ T hybridoma cells that were transiently transfected 
with cDNAs encoding Ly108-1, Ly108-2, or Ly108-H1. Surface expression was evaluated by flow cytometry 24 h after transfection. (C) Lysates of the 
Ly108-1, Ly108-2, or Ly108-H1 BI-141 transfectant cells were immunoprecipitated with -Ly108, treated with PNGaseF, subjected to SDS-PAGE, and 
evaluated by Western blotting (WB) with the R4 polyclonal antibody. IP, immunoprecipitate. (D) Schematic illustration of the three Ly108 protein isoforms. 
Antibody R1 binds a segment shared by the isoforms Ly108-1 and Ly108-2. Antibody R4 is directed against the C-terminal amino acid sequence of iso-
forms Ly108-2 and Ly108-H1. (E) RT-PCR analyses of isoform mRNAs isolated from thymocytes of Slamf-haplotype 1 and 2 WT and congenic mouse 
strains. Primers specific for exons 5 and 8 recognize Ly108-1, and primers specific for exons 5 and 9 recognize Ly108-2 and Ly108-H1. Plasmids contain-
ing the cDNA sequences of individual isoforms (pLy108-1, pLy108-2, and pLy108-H1) were used as positive controls. (F) RT-PCR analyses of isoform 
mRNAs isolated from B cell lines. B6-206 and B6-208 are cloned B cell lymphoma lines derived from B6 mice. WEHI-231 and A20 are derived from BALB/c 
mice (Slamf-haplotype 2). All T cell experiments were performed two times; the B cell analysis was performed once using two different cell lines from 
each of the haplotypes.JEM VOL. 208, April 11, 2011 
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and by the possibility of overexpressing the transgene in a tissue-
biased manner. We therefore introduced into the Sle1b mouse a 
B6-derived BAC clone–based transgene, which only expressed 
Ly108-H1. This required several alterations of the BAC clone 
RP23-77A8  (Osoegawa  et  al.,  2000).  First,  through  recom-
bineering in Escherichia coli, we removed a DNA fragment con-
taining Ly108 exons 7 and 8, thus preventing potential expression 
of Ly108-1 and Ly108-2 by the transgene. Next, the genomic 
sequences encoding SLAM (Slamf1) and CD84 (Slamf5) were 
removed by two subsequent recombineering steps. Because the 
Ly108 amino acid sequence does not differ between haplotype 
1 and haplotype 2 strains, the transgene simply reconstructed a 
missing splicing event in the transcriptome of Sle1b mice. The 
resulting 100-kb genomic BACLy108-H1 vector should only 
contain the genomic cis-sequences that are requisite for faithful 
transcription of only the Ly108-H1 isoform (Fig. 4 A).
Transgenesis of the BACLy108-H1 vector into Sle1b mice 
resulted in the Sle1b.BACLy108-H1 mouse with the trans-
gene located in one area of the genome, as judged by fluores-
cent  in  situ  hybridization  (Fig.  S4 A).  Semiquantitative 
RT-PCR indicated that Ly108-H1 was expressed in thymo-
cytes derived from hemizygous transgenic Sle1b.BACLy108-
H1  mouse,  while  absent  in  Sle1b  thymocytes  (Fig.  4  B).   
To further evaluate the faithful transcription of all three of the 
Ly108 isoforms, we took advantage of the fact that Ly108 
transcripts originating from B6 and Sle1b differ from each 
other in several synonymous SNPs (NCBI mouse SNP data-
base). Indeed, the Sle1b.BACLy108-H1 mice express exons 
2–4 both of Slamf-haplotype 1 (encoded by BACLy108-H1) 
and of Slamf-haplotype 2 (encoded by Sle1b; Fig. 4 C). Exam-
ination of the RFLPs of thymocyte-derived Ly108 cDNA 
confirmed that Ly108-1/2 expression in Sle1b.BACLy108-H1 
thymocytes was controlled by the Slamf-haplotype 2 segment 
of the Sle1b mouse (Fig. 4 D, left). The BAC transgene did not 
express SLAM and CD84, as judged by the use of two differ-
ent SNP-based RFLPs (Fig. 4 D, middle and right).
Cytofluorimetric analyses of Ly108 expression on the sur-
face of T lineage cells isolated from Sle1b, Sle1b.BACLy108-H1, 
or B6 mice (Fig. 4 E) supported the notion that Ly108 
surface expression on T cells was slightly higher in hemizygous 
Sle1b.BACLy108-H1 mice than their Sle1b transgene-negative 
littermates. And, as expected for mice that are hemizygous for the 
Ly108-H1 transgene and homozygous for the Slamf-haplotype 
2 forms of Ly108, surface expression was not as high as on the 
surface of Slamf-haplotype 1, e.g., B6 thymocytes (Figs. 2 and 4 E). 
The overall T and B lymphocyte development was normal 
in young Sle1b.BACLy108-H1 mice (Fig. S4 B). Collectively, 
these results indicate that, at most, one copy of Ly108-H1 was 
expressed in Sle1b.BACLy108-H1–derived T lineage cells and 
that cell surface expression and balance between the three iso-
forms was similar to that found in the B6 mouse.
The presence of the Ly108-H1 isoform in Sle1b mice 
ameliorates the development of lupus-related autoimmunity
To assess whether Ly108-H1 would affect the spontaneous 
development of SLE in Sle1b mice, we analyzed a cohort 
molecular weight and reactivity with R4 (Fig. 3 C). Collectively, 
these data clearly demonstrate that T and B lineage cells from 
haplotype 1 but not haplotype 2 mice express Ly108-H1, in 
addition to the Ly108-1 and Ly108-2 proteins (Fig. 3 D).
Next, expression of Ly108-H1 in T and B cells from the 
lupus-prone congenic strains Sle1b and B6.129chr1b and 
from various Slamf-haplotype 1 and 2 mice was examined by 
RT-PCR. To this end, oligonucleotide primers that either 
spanned exons 5–8 (detecting Ly108-1) or exons 5–9 (com-
mon to Ly108-2 and Ly108-H1) were used. Ly108-H1 was 
detectable in Slamf-haplotype 1 but not in any haplotype 2 
thymocytes (Fig. 3 E). More importantly, Ly108-H1 is absent 
in the congenic mouse strains Sle1b and B6.129chr1b, sug-
gesting that the presence of this novel protein isoform might 
affect the development of lupus.
To evaluate whether single cells express all three isoforms, 
we used B cell lymphoma cell lines from different origins. 
These experiments showed that the B6-derived lines B6-
206 and B6-208 coexpressed transcripts for all three isoforms, 
whereas the BALB/c-derived A20 and (BALB/c × NZB)F1-
derived WEHI-231  cells  coexpressed  only  Ly108-1  and 
Ly108-2 (Fig. 3 F).
The data with Sle1b and B6.129chr1b lymphocytes sug-
gest that the alternate splice form, Ly108-H1, might have 
been generated by regulatory elements within the short 129-
derived segment in these congenic mouse strains and perhaps 
by elements that are part of, or in proximity to, the Ly108 
gene. To evaluate this, a B6-derived and a 129-derived BAC 
clone were each transfected into Jurkat T cells. Both transfec-
tant cells expressed Ly108-1 and Ly108-2, but only in trans-
fectants  generated  with  the  B6-derived  BAC  clone  could 
Ly108-H1 be detected (Fig. S3, A and B). Our sequence analy-
ses indicated that the splice donor and acceptor sequences 
in the introns surrounding exons 6–8 are identical between 
B6 and the congenic mouse strains Sle1b and B6.129chr1b 
(Fig. S3 C). However, two pyrimidine-rich tandem repeat se-
quences were only present in intron 6 of the B6 mouse 
(Fig. S3 C), which could be the cause for the alternate splic-
ing events that generate the protein isoform Ly108-H1 (Wagner 
and Garcia-Blanco, 2001; Black, 2003).
Collectively, these data clearly demonstrate that T and 
B lymphocytes from Slamf-haplotype 1 but not haplotype 2 
mice coexpress the Ly108-1, Ly108-2, and Ly108-H1 protein 
isoforms. We conclude that Ly108-H1 is generated by ele-
ments within the B6-derived BAC clone, most likely by se-
quences in intron 6, which could negatively regulate splicing 
and which are absent in Slamf-haplotype 2 mice.
Faithful expression of an Ly108-H1 BAC-based transgene 
BACLy108-H1 in Sle1b mice
Because Ly108-H1 is not expressed in the congenic Sle1b and 
B6.129chr1b mice, we hypothesized that this isoform could have 
a protective role in murine lupus. To this end, we introduced the 
Ly108-H1 isoform into the Sle1b mouse. However, introduc-
tion of an Ly108-H1–specific transgene might be complicated 
by regulatory elements in and in proximity to the Ly108 gene 816 Novel isoform of Ly108 protects against lupus | Keszei et al.
We  conclude  that  the  presence  of  Ly108-H1  partially 
suppresses the key humoral autoimmune features of  Sle1b 
mice, i.e., autoantibody production, spontaneous activation of 
peripheral T cells, and expansion of germinal center B cells. 
This is remarkable because the DNA segment derived from 
NZW, i.e., Slamf-haplotype 2, contains 7 Slamf genes and >12 
other genes, which might somehow contribute to Sle1b-based 
lupus (Wandstrat et al., 2004; Calpe et al., 2008).
Ly108-H1 in CD4+ T cells ameliorates autoimmunity  
in a transfer model of SLE
Whereas previous studies indicate that a defect in early B cell 
development is a major contributor to lupus in the Sle1b 
mouse (Kumar et al., 2006; Chang et al., 2009), a role for pe-
ripheral T cells cannot be excluded in this congenic mouse. 
We therefore directly tested the possibility that Sle1b CD4+  
T cells could induce autoantibody production in an estab-
lished transfer model of SLE (Morris et al., 1990). As shown 
in Fig. 6 A, the transfer of Sle1b splenocytes into bm12 recipi-
ents  induces  much  higher  anti–double-stranded  DNA   
(dsDNA) IgG titers than the transfer of splenocytes derived from 
WT B6 mice, particularly at 4 wk after transfer. Second, both 
purified Sle1b CD4+ T cells or CD62L+ naive CD4+ T cells 
(Fig. 6 B and Fig. S5, A–E) consistently induced stronger   
of aged female hemizygous Sle1b.BACLy108-H1 mice and 
transgene-negative Sle1b littermate controls along with B6 
females. Whereas the Sle1b mice (6–8 mo old) had high titers 
of antinuclear antibodies (ANAs), as judged in a HEp-2 cell–
based fluorescence quantitative assay, spontaneous develop-
ment of these autoantibodies was significantly lower in their 
transgenic littermates (Fig. 5 A). Similarly, antinucleosome 
IgG and antichromatin IgG titers were dramatically lower 
in Sle1b.BACLy108-H1 as compared with the Sle1b mice 
(Fig. 5, B and C).
The presence of the Ly108-H1 transgene in aged Sle1b 
mice affected the activation of T and B cells (Table S1). First, 
in aged Sle1b mice, a significant increase in activated CD69+ 
and CD44+CD62L effector/memory CD4+ T cells was found 
compared with B6 mice. This effect was strongly reduced by the 
presence of the Ly108-H1 transgene (Fig. 5 D and Table S1). 
To exclude transgene integration site–dependent artifacts, we 
also demonstrated this phenotype in a second independently 
derived BACLy108-H1 transgenic founder line (Fig. S4, C–E). 
Similarly, the percentage of IFN-–expressing CD4+ cells was 
lower in aged Sle1b.BACLy108-H1 mice than in Sle1b mice. 
The spontaneous expansion of germinal center B cells and 
contraction of the marginal zone B cells in Sle1b mice was 
substantially reversed by Ly108-H1 (Fig. 5 E and Table S1).
Figure 4.  Expression of an Ly108-H1 BAC-based transgene 
in Sle1b mice. (A) The BACLy108-H1 transgene vector encoding 
Ly108-H1 was generated by deleting exons 7 and 8 of Ly108 and 
the SLAM and CD84 genes from the B6 BAC clone RP23-77A8. 
Alteration of the 200-kb B6 BAC clone by Red/ET recombineering 
is described in Materials and methods. The resulting DNA frag-
ment BACLy108-H1 is 100 kb. S1, S2, S3, and S4 are homology 
arms for Red/ET recombination. KANA is a kanamycin resistance 
gene cassette. (B) RT-PCR prepared with thymic mRNA using 
Ly108-H1–specific primers. (C) Haplotype (Hap)-specific RFLP 
fragments were obtained by BsrI digestion of PCR-amplified thy-
mic Ly108 cDNA. B6 and Sle1b mice exclusively express haplotype  
1– and haplotype 2–specific fragments, respectively. Because 
Sle1b.BACLy108-H1 mice express both fragments, the transgene  
expresses the B6 based fragment. PCR primer pairs specific for 
Ly108 exons 2–4 (common for Ly108-1, Ly108-2, and Ly108-H1) 
were used, as described in Materials and methods. (D, left) RT-PCR 
primers specific for Ly108 exons 2–7 (common for Ly108-1 and 
Ly108-2 only) were used to isolate a cDNA from the thymus. Hap-
lotype 1– and haplotype 2–specific RFLP used BsrI digestion, as in C. 
(middle) RT-PCR primers specific for SLAM exons 1–5 were used  
to isolate a cDNA from the thymus. Haplotype 1– and haplotype 
2–specific RFLP fragments were obtained by TaqI digestion. (right) 
RT-PCR primers specific for CD84 exons 1–2 were used to isolate 
cDNA. Haplotype-specific RFLP fragments were obtained by MspI 
digestion. (E) Cell surface expression of Ly108 using T lineage cells 
isolated from Sle1b, Sle1b.BACLy108-H1, or B6 mice. Thymic and 
splenic T cells were incubated with the monoclonal -Ly108 anti-
body (13G3) conjugated with DyLight 649 and then washed and 
analyzed by flow cytometry. The mean fluorescent intensity (MFI) 
of gated cell populations in the DyLight 649 channel is shown 
(three to four individual mice per group). PCR experiments were 
performed a minimum of two times. DN, double negative;  
DP, double positive.JEM VOL. 208, April 11, 2011 
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T cells. We conclude that a balanced expression of the Ly108-
H1 isoform in CD4+ T cells ameliorates SLE in Sle1b mice 
and may dampen in vivo and in vitro T cell activations.
DISCUSSION
In mice, genome-wide linkage studies have implicated the 
syntenic region to human 1q23 in three different models of 
spontaneous  lupus:  the  (NZB  ×  NZW   )F2  intercross,  the 
NZM/Aeg2410 New Zealand mice, and the BXSB mice 
(Kono et al., 1994; Rozzo et al., 1996; Hogarth et al., 1998). 
The phenotype of these mice is very similar to that in SLE 
patients, with the production of autoantibodies, as well as 
multiorgan involvement, including severe nephritis. In con-
genic mice derived from the NZM2410 mouse strain and B6, 
the locus on chromosome 1, i.e., Sle1, by itself was sufficient 
to generate a strong, spontaneous, humoral ANA response. Sle1 
also led to an expanded pool of histone-reactive T cells. Thus, 
Sle1 may lead to the presentation of chromatin in an immuno-
genic fashion or directly impact tolerance of chromatin-
specific B cells. Consequently, Sle1 is thought to be a major 
player in orchestrating selective loss of B cell and T cell toler-
ance to chromatin. Fine mapping of the Sle1 locus deter-
mined that three loci within this congenic interval, termed 
Sle1a, Sle1b, and Sle1c (Morel et al., 2001), could indepen-
dently cause a loss of tolerance to chromatin, which is a nec-
essary step for full disease induction. The Sle1b region, an 
0.9-Mb  Slamf-haplotype  2–derived,  i.e.,  NZW-derived, 
DNA segment which includes the Slamf locus, was impli-
cated as a major contributor to the role of Sle1b in tolerance 
(Wandstrat et al., 2004).
Similar to the Sle1b mouse, B6.129chr1b mice also de-
velop lupus (Bygrave et al., 2004; Carlucci et al., 2007).   
In  these  mice,  the  Slamf  genes  are  derived  from  the  129  
autoantibody  responses  when  transferred  into  bm12  mice 
than the transfer of the same cells isolated from WT B6 mice. 
This result strongly supported a role for peripheral CD4+  
T cells in the spontaneous Sle1b disease.
A comparison of autoantibody responses to the transfer of 
cells derived from Sle1b or Sle1b.BACLy108-H1 mice into 
bm12 recipients showed that Ly108-H1–expressing spleno-
cytes or CD4+ T cells ameliorate autoreactive responses (Fig. 6, 
C and D; and Fig. S5, D and E). Furthermore, transferring 
Sle1b.BACLy108-H1 splenocytes or CD4+ T cells into bm12 
recipients induces less CD4+ T cell activation (Fig. 6 E) than 
transfer of Sle1b-derived cells. Similarly, less B cell activation 
is found upon transfer of Sle1b.BACLy108-H1 cells com-
pared with Sle1b cells (Fig. S5 F).
An  in  vitro  experiment  confirmed  the  notion  that 
Ly108-H1 affects T cell proliferation when naive CD4+ T cells 
isolated from Sle1b, Sle1b.BACLy108-H1, and B6 mice were 
stimulated with limiting amounts of -CD3. Under the con-
ditions used, Sle1b CD4+ T cells responded with a robust pro-
liferation (Fig. 6 F), suggesting that they are indeed intrinsically 
prone to undesirable immune activation. However, as pre-
dicted by our in vivo observations (Fig. 6 D and Fig. S5 E), 
this phenotype of naive CD4+ Sle1b T cells was dramatically 
reduced in naive Sle1b.BACLy108-H1 CD4+ T cells (Fig. 6 F). 
Similar results were obtained with measuring proliferation by 
CFSE dilution (Fig. S5 G).
Collectively, the outcomes of this set of experiments dem-
onstrate that, in contrast to previous suggestions that Ly108 
controls T and B cell development (Kumar et al., 2006; Kanta 
and Mohan, 2009), peripheral Sle1b CD4+ T cells play a major 
role in the pathogenesis of SLE. More importantly, the trans-
fer of Ly108-H1–expressing Sle1b T cells causes significantly 
less disease than the transfer of the same number of Sle1b  
Figure 5.  The presence of the Ly108-H1 isoform in Sle1b mice ameliorates spontaneous development of SLE. All experiments in this figure 
were performed using sera (A–C) or splenocytes (D and E) from one cohort of 6–8-mo-old female mice: B6, n = 12; Sle1b, n = 14; Sle1b.BACLy108-H1,  
n = 15. (A) Comparison of ANA titers in aged Sle1b, Sle1b.BACLy108-H1, and B6 mice. Monolayers of permeabilized HEp-2 cells were incubated with sera 
from 6–8-mo-old female mice. The cells were washed, and bound IgG was detected with anti–mouse IgG–Alexa Fluor 488 and quantitated by fluorescent 
microscopy (see Materials and methods). Statistical analyses were performed as in Fig. 1. (B) Antinucleosome antibody titers in sera of 6–8-mo-old female 
Sle1b, Sle1b.BACLy108-H1, and B6 mice was detected by ELISA (see Materials and methods). (C) Antichromatin antibody titers were detected as in B.  
(A–C) The mean titer is indicated by a horizontal bar. EU, ELISA units. (D) Number of CD69+CD4+ activated T cells in the spleen of aged Sle1b.BACLy108-H1 
and Sle1b mice. Staining and flow cytometry were performed as described in Materials and methods. (E) Number of germinal center B cells (GL7hi Fashi 
B220+) in the spleen of aged Sle1b.BACLy108-H1 and Sle1b mice. Staining and flow cytometry were performed as described in Materials and methods.  
(D and E) Error bars indicate SEM of samples from 12–15 animals per group.818 Novel isoform of Ly108 protects against lupus | Keszei et al.
nonautoimmune genetic background, supporting the theory 
that autoimmunity occurs because of unidentified epistatic 
genetic interactions between the haplotype 2 Slamf locus and 
the B6 background genes (Morel et al., 1999; Bygrave et al., 
2004; Wandstrat et al., 2004; Carlucci et al., 2010). The exper-
iments in this paper set out to demonstrate that elimination in 
the congenic mouse Ly108/ [129 × B6] of both Ly108-1 
and Ly108-2 leads to an absence of disease when compared 
with the control mouse Ly108+ B6.129chr1b. Surprisingly, 
protein analyses identified the novel Slamf-haplotype 1– 
specific isoform Ly108-H1, which has only one of the two 
ITSMs that binds the SH2 domain adapter SLAM-associated 
protein (SAP) in T and NK cells. The mechanism, which leads 
to this alternative splice form being expressed exclusively in 
Slamf-haplotype 1 mice, is located within the Ly108 gene 
itself. First, the observation that Ly108-H1 is not expressed in 
Sle1b, which is a B6 mouse with an 0.9-Mb insert derived 
from the Slamf-haplotype 2 mouse NZW (Wandstrat et al., 
2004), suggests that this small genomic inset is endowed with 
the capability to control this particular alternative splicing 
event. Second, several DNA sequences, which could influ-
ence local splicing, are present in intron 6 of B6 but not in the 
Slamf-haplotype 2 mice. Third, Jurkat cells transfected with 
the Ly108 containing B6-derived BAC clone (RP23-77A8) 
express Ly108-H1 messenger RNA (mRNA), which is not 
detectable in Jurkat cells transfected with the 129-derived 
BAC clone (bMQ241k20).
Several recent studies support a model in which T cells 
isolated from SLE patients surprisingly express protein iso-
forms that are infrequently found in cells from healthy indi-
viduals.  For  instance,  unusual  CD3-  and  CD44  isoform 
mRNAs have been found in lupus patients, which lead to 
mutant  CD3-  proteins  that  alter TCR/CD3  signaling 
(Nambiar et al., 2001; Tsuzaka et al., 2003; Crispín et al., 
2010a). Similarly, some isoforms of the IRF5 gene, which is 
genetically associated with lupus (genome-wide association 
study SNP), are highly expressed in patients but not in healthy 
individuals (Graham et al., 2006). Furthermore, only the short 
isoform of CD244 (SLAMF4), which is an alternative splicing 
product, was associated with lupus (Kim et al., 2010). How 
the alternate splice forms of mouse Ly108-1 and Ly108-2 are 
generated is not known in detail, but the presence of two 3 
untranslated region sequences in all healthy mice suggests that 
the decision process might be stochastic (Fig. S3 B). Although 
the presence or absence of Ly108-H1 protein marks the 
major difference between Ly108 in Sle1b and B6 mice, we 
cannot exclude the idea that subtle differences in expression 
of Ly108-1 and Ly108-2 contribute to cooperation between 
the three isoforms in a given cell. In addition to the two well 
characterized isoforms, Zhong and Veillette (2008) recently 
Figure 6.  The presence of Ly108-H1 in Sle1b CD4+ T cells amelio-
rates SLE in a transfer model of SLE. (A) 5 × 107 splenocytes isolated 
from individual B6 or Sle1b mice were transferred into bm12 recipients by 
i.p. injection. After 4 or 10 wk, anti-dsDNA antibodies in the serum were 
determined by ELISA and are expressed as ELISA units (EU). B6 → bm12,  
n = 14; Sle1b → bm12, n = 12. Data points shown are pooled from two 
experiments. (B) 7 × 106 CD4+ T cells isolated from B6 or Sle1b mice were 
transferred into bm12 recipients by i.p. injection. After 4 or 10 wk, anti-
ssDNA antibodies in the serum were determined by ELISA and were ex-
pressed as ELISA units. B6 → bm12, n = 5; Sle1b → bm12, n = 6.  
(A and B) Statistical analyses were performed as in Fig. 1. Median values are 
indicated by a horizontal line. (C) 5 × 107 Splenocytes isolated from individual 
donors were transferred into bm12 recipients by i.p. injection. After 4 wk, 
anti-dsDNA IgG autoantibodies were determined. B6 → bm12, n = 7; 
Sle1b.BACLy108-H1 → bm12, n = 5; Sle1b → bm12, n = 7. (D) 2.5 × 106 
naive (CD62L+) CD4+ T cells isolated from the spleen of B6, Sle1b, or  
Sle1b.BACLy108-H1 mice were transferred into bm12 recipients by i.p. 
injection. After 4 wk, anti-ssDNA antibodies in the serum were deter-
mined by ELISA and are expressed as ELISA units. B6 → bm12, n = 5; 
Sle1b.BACLy108-H1 → bm12, n = 4; Sle1b → bm12, n = 4; bm12 → bm12,  
n = 3. (C and D) Statistical analyses were performed as in Fig. 1. (E) CD4+  
T cell activation upon transfer of B6, Sle1b.BACLy108-H1, and Sle1b 
splenocytes into bm12 recipients. See C. (F) Naive CD4+ T cells isolated from 
the spleen of the indicated mice were activated with a suboptimal dose of 
anti-CD3 and anti-CD28. Proliferation was determined by pulsing with 
[3H]thymidine on day 2 and harvesting 16 h later. Mean and SEM of three 
samples (105 cells/well) generated from the pool of two animals. The re-
sult is representative of two independent experiments (statistical analysis 
by two-tailed unpaired t test).
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differences  between  the  Ly108  isoforms,  it  is  likely  that 
Ly108-H1 mediates distinct inhibitory signaling events rather 
than passively interfering with signals initiated by Ly108-1 
and Ly108-2. This hypothesis is supported by the observation 
that the BACLy108-H1 transgene only causes a small increase 
in total Ly108 surface expression on peripheral CD4+ T cells, 
making it improbable that Ly108-H1 is affecting clustering of 
the other Ly108 molecules in the immunosynapse. Addition-
ally, expression of the Ly108-H1 transgene dampens prolifer-
ation in CD4+ T cells, whereas Ly108/ mice maintain 
normal levels of proliferation (Howie et al., 2005; unpub-
lished data generated with B6.Ly108/), further supporting 
the notion that Ly108-H1 is an active signaling molecule. As 
yeast two-hybrid screenings have identified that both ITSMs, 
associated with the Y295 and Y319 of Ly108, are capable of 
binding SAP (Fraser et al., 2002), it is likely that Ly108-H1, 
which also contains one of these motifs, is also capable of re-
cruiting the adapter protein SAP. Additionally, as Ly108 was 
recently shown to participate in stabilizing T cell–B cell 
conjugate formation in a SAP-binding dependent manner 
(Cannons et al., 2010), dissecting the role of Ly108 isoforms 
in cell–cell networking processes that govern autoantibody 
production could be an exciting area for further investiga-
tions. As an interest in gene isoform–dependent mechanisms 
is rapidly increasing and because isoform expression appears 
to be altered in lupus patients, the outcomes of our experi-
ments relate to a larger concept that an interplay between 
isoforms provides for a plethora of regulatory possibilities in 
developmental biology, as well as in pathogenesis of diseases.
MATERIALS AND METHODS
Mice.  B6,  NOD/LtJ,  MOLF/EiJ,  BALB/c,  and  B6.C-H-2bm12/KhEg 
(bm12) mice were obtained from the Jackson Laboratory. 129/SvEvTac (129) 
mice were obtained from Taconic. B6.129chr1b (Carlucci et al., 2007) mice 
were donated by M. Botto (Imperial College London, London, England, UK). 
B6.Sle1b (Sle1b; Morel et al., 2001) mice were provided by L. Morel (Univer-
sity of Florida, Gainesville, FL). Ly108/ [129 × B6] (Howie et al., 2005) was 
backcrossed six times with B6, and breeders were selected for the smallest 
congenic interval. Animal experiments were approved by the Beth Israel Dea-
coness Medical Center Institutional Animal Care and Use Committee.
reported a rare transcript termed Ly108-3. This isoform, when 
ligated, mediates a tyrosine phosphorylation signal that is in-
termediate between Ly108-1 and Ly108-2. This protein iso-
form could not be detected in our experiments.
Transgenesis  of  the  BACLy108-H1  vector  encoding 
Ly108-H1 into Sle1b mice had a dramatic effect on the spon-
taneous development of lupus. Remarkably, expression of 
Ly108-H1 significantly decreased autoantibody titers, per-
centages of spontaneously activated T and B cells in the 
spleen, and expansion of germinal center B cells in aged 
Sle1b.BACLy108-H1 mice compared with their Sle1b litter-
mate controls. Despite not completely reversing the auto-
reactive  phenotype  normally  observed  in  Sle1b  mice,  our 
results indicate that Ly108-H1 is a major player in regulating 
Ly108-mediated autoimmunity. This lack of a full phenotype 
reversal can be explained in part by our semiquantitative PCR 
data, which suggest that Ly108-H1 is expressed at lower levels 
in the hemizygous transgenic animals than in the B6 mouse 
(Fig. 4 B). Moreover, in Sle1b mice, the putative pathogenic 
isoform, Ly108-1, has an elevated expression level compared 
with the B6 mouse (Wandstrat et al., 2004), which might be 
difficult to overcome by inhibitory signals.
Although activation of both T and B cells was affected by 
the presence of Ly108-H1, we focused on the role of periph-
eral CD4+ T cells in transfer experiments. Although T cells in 
the Sle1 congenic mice show a broad range of autoimmune 
phenotypes (e.g., spontaneous CD4+ T cell activation, decreased 
number of T regulatory cells, presence of histone-specific   
T cells, and increased proliferation and cytokine production; 
Morel et al., 2001; Chen et al., 2005), the Sle1b subcongenic 
mice carry only a fraction of these defects (i.e., increased per-
centage of activated T cells and elevated calcium influx after 
receptor cross-linking [Wandstrat et al., 2004; Chen et al., 
2005]). In this study, we show that the transfer of peripheral 
CD4+ cells derived from Sle1b mice into bm12 recipients in-
duces T and B cell activation and autoantibody responses that 
are much more robust than after the transfer of B6 cells, work 
that directly links, for the first time, T cell–intrinsic phenotypes 
of Sle1b with lupus development. The transfer of Sle1b cells 
expressing Ly108-H1 results in a much lesser autoantibody 
and T cell responses compared with the responses to Sle1b 
cells. This ameliorating effect of Ly108-H1 is caused by a mecha-
nism that results in dampening in vivo and in vitro T cell pro-
liferation and not by reduced activation-induced cell death.
Recently, experiments with Sle1b-derived B cells led to 
the conclusion that Ly108-2, in contrast to Ly108-1, is able to 
sensitize immature B cells to deletion (Kumar et al., 2006). 
Preliminary  transfections  in WEHI-231  cells  (unpublished 
data) suggest that in contrast to Ly108-2, Ly108-H1 does not 
affect apoptosis. In the model in Fig. 7, we therefore hypothe-
size that Ly108-1 is a pathogenic allele that operates in im-
mature B cells and peripheral T cells. Ly108-2 and the novel 
isoform Ly108-H1 are both associated with disease protec-
tion: whereas Ly108-2 contributes to sensitizing T and B cells 
to apoptosis, Ly108-H1 is an effective suppressor of patho-
genic T cell proliferation in Sle1b. Based on these functional 
Figure 7.  Schematic outline of the proposed role of the Ly108 
protein isoforms in the pathogenesis of disease in Sle1b mice.820 Novel isoform of Ly108 protects against lupus | Keszei et al.
no.  rs31528577)  primers:  forward,  5-ATGGCCCAGCGCCATCTGTG-
GATC-3;  and  reverse  5-TCTTGGTGATGGTTTCCTCA-3  digested 
with MspI.
Generation of monoclonal antibodies directed against murine Ly108. 
Monoclonal antibodies directed against Ly108 were generated by immuniz-
ing an Ly108-deficient mouse (Howie et al., 2005) with WT thymocytes. 
Splenocytes were fused with NS1 myeloma cells and selected according to 
standard protocols. After three rounds of subcloning, the clone 13G3 (IgG2a) 
was selected based on reactivity with Ly108-Fc, as judged by ELISA.
Polyclonal antibodies. Antisera R1 and R4 directed at the cytoplasmic 
tails of Ly108 isoforms were generated by immunizing female New Zealand 
white rabbits with peptides conjugated via the N-terminal cysteine to KLH 
(Thermo Fisher Scientific). Antiserum R1, which recognizes both Ly108-1 
and  Ly108-2,  was  generated  against  the  peptide  Cys-KNDSMTIY-
SIVNHSRE.  Antiserum  R4,  recognizing  Ly108-2  and  Ly108-H1,  was 
directed against the peptide Cys-ALTGYNQPITLKVNTLINYNS.
Immunoprecipitation  and Western  blotting. Ly108 was precipitated 
from cell lysates with -Ly108 (13G3) and protein G agarose (Invitrogen). 
Purified proteins were resolubilized before deglycosylation at 37°C for 2 h 
with immobilized carbohydrate binding domain–PNGaseF fusion protein 
(CBM-PNGaseF), donated by A. Warren (University of British Columbia, 
Vancouver, British Columbia, Canada). Isoforms were separated on a 12% 
continuous SDS-PAGE gel with MOPS (morpholino propane sulfonic acid) 
running buffer (Invitrogen). After transfer to polyvinylidene fluoride mem-
brane, Western blotting was performed with the indicated rabbit primary and 
anti–rabbit, light chain–specific secondary horseradish peroxidase–conjugated 
antibody (Jackson ImmunoResearch Laboratories, Inc.). Reactivity was de-
tected by chemiluminescence with SuperSignal (Thermo Fisher Scientific).
Expression vectors. Ly108 isoforms were amplified by PCR with primers 
introducing XhoI and XbaI restriction sites and cloned into pCR2.1-TOPO 
(Invitrogen) before subcloning into the mammalian expression vector PCI-
neo (Promega). Ly108-1 and Ly108-2 cDNAs were provided by E. Ruley 
(Vanderbilt University School of Medicine, Nashville, TN; Peck and Ruley, 
2000). Ly108-H1 was amplified from B6 thymus cDNA.
Cell transfection. Ly108 isoforms were transfected into 1–2 × 107 cells by 
electroporation (250 V and 960 µF) with 10 µg plasmid DNA in 400 µl 
OptiMEM (Invitrogen) using a cuvette with a 4-mm electrode gap (Bio-Rad 
Laboratories) and analyzed 24 h later.
Flow  cytometry. Single cell suspensions of spleens and thymuses were 
stained with the following antibodies after blocking nonspecific binding with 
CD16/32 (93) and 20% rabbit serum or 10% rabbit serum, respectively: 
-CD3 (17A2), -CD4 (L3T4), –CD8- (53–6.7), -CD19 (1D3), -CD21 
(eBio4E3), -CD23 (B3B4), -CD44 (IM7), -CD62L (MEL-14), -CD69 
(H1.2F3), -CD86 (GL-1), -CD138 (281–2), -B220 (RA3-6B2), -Fas 
(Jo2), -GL7 (GL-7), –TCR- (H57-597) purchased from eBioscience, 
BD, or BioLegend. PBS57-loaded CD1d tetramer was provided by the National 
Institutes of Health tetramer facility. When surface Ly108 staining was performed, 
we used Cy5- or DyLight 649–conjugated anti-Ly108 (13G3) or IgG2a isotype 
control. Data were acquired with a cytometer (LSRII; BD) and analyzed using 
FlowJo software (Tree Star). Dead cells were excluded upon DAPI uptake. For 
intracellular staining, we used IFN- (XMG1.2) and IL-2 (JES6-5H4) anti-
bodies (from BioLegend and BD, respectively) after 5-h PMA (50 ng/ml) and 
ionomycin (1 µg/ml) activation and cell permeabilization (BioLegend kit). 
When aged mice from a cohort were analyzed on different days (Fig. 1 B), 
each flow cytometry assay included at least one age-matched WT control.
ELISA. Titer of antinucleosome (antihistone–DNA complex) antibodies in 
mouse sera were determined by ELISA as described previously (Mohan et al., 
1998).  In  brief,  met-BSA–precoated  Immunolon  (Dynatech)  plates  were 
Genotypic  analysis.  Genomic  DNA  of  Ly108/  [129  ×  B6]  and 
B6.129chr1b mice was analyzed with polymorphic genetic markers. PCR 
was performed using 10 markers on chromosome 1 and at least 1 marker per 
other chromosomes. Primer sequences were obtained from the Mouse Ge-
nome Informatics database. Fine mapping of congenic boundaries was per-
formed by the Jackson Laboratory (JAX Mouse Diversity Genotyping Array 
Service). In brief, mouse genomic DNA was labeled and hybridized on a 
custom Affymetrix array. The mean resolution of the analysis was one SNP 
every 4.3 kb.
Generating  the  Sle1b.BACLy108-H1  mice.  RP23-77A8  BAC  clone, 
containing full-length B6 Ly108, CD84, and SLAM, was obtained from the 
BACPAC Resources Center at Children’s Hospital Oakland Research Insti-
tute. Exons 7–8 and the surrounding intronic region of the Ly108 gene were 
removed by Red/ET recombination (Muyrers et al., 1999) using a commer-
cial kit (Gene Bridges GmbH) according to the manufacturer’s protocol. In 
brief,  S1  (5-TAAAGGAGCAAGCCTGGAATCAGATGCAAGACAAG-
AATGCTTTTATCCCT-3) and S2 (5-AATACACAGAAGTAGACCTA-
CAGTTGCAGAGCCAATCATATTGTTTCATT-3) homology arms were 
used to target a 2.8-kb fragment containing Ly108 exons 7 and 8 and replac-
ing it with a single PmeI site. To remove a 130-kb genomic region containing 
SLAM and CD84, we performed a second recombination step using S3   
(5-AGGTCATCCTCTATCCTAACCTCAGAGAAGCACTTCCTGCA-
CATCACTAG-3) and S4 (5-GTTATGGACATGATCTGCATTCATGT-
TCATGGGCATTTAGGATTTCACTG-3)  homology  arms. Vector  was 
injected into Sle1b oocytes by the Beth Israel Deaconess Transgenic Core 
Facility. Screening of founders was performed by PCR.
Murine transfer model of lupus. As described by Morris et al. (1990), 
7–9-wk-old naive female bm12 mice were injected i.p. with splenocytes, 
purified CD4+ T cells, or purified CD62L+ CD4+ naive T cells (magnetic 
bead cell separation; Miltenyi Biotec) from age- and sex-matched donors.
RT-PCR. RNA was isolated from cells using the RNeasy kit (QIAGEN) 
or TRIZOL (Invitrogen). RT was performed with the Protoscript cDNA 
kit (New England Biolabs, Inc.). A full-length RT-PCR was performed   
on cDNA templates with the following primers with introduction of restric-
tion  sites:  5  XhoI-Ly108-1/2/H1  start,  5-GGCTCGAGATGGCT-
GTCTCAAGGGCT-3; 3 Ly108-1 end XbaI, 5-GGTCTAGATTA-
AGAGTATTCGGCCTCTCTGG-3; and 3 Ly108-2/H1 end XbaI, 
5-GGTCTAGATCAGGAGTTATAGTTGATTAAAGTGTT-3.
A shorter PCR was performed for better separation of the isoforms with 
the following primers: 5 (in exon 5), 5-TTTGACTAGCCAACATCC-3; 
3 Ly108-1, 5-TTAAGAGTATTCGGCCTC-3; and 3 Ly108-2/H1,   
5-TCAGGAGTTATAGTTGAT-3. RT-PCR for selective amplification of 
Ly108-H1 was performed with the primers Ly108-H1 forward, 5-CCTA-
CTCCCTGCAAATCAGC-3;  and  Ly108-H1  reverse,  5-CCGGTTA-
AAGCCACTGTTTCCTG-3. GAPDH-specific primers were obtained from 
New England Biolabs, Inc.
Haplotype-specific RT-PCR and RFLP. For RFLP assays, polymorphic 
Ly108, SLAM, and CD84 cDNA fragments were amplified by PCR. All ampli-
fied fragments contained haplotype-specific SNPs (NCBI dbSNP or Mouse 
Genome Informatics databases) with allele-selective restriction digestibility. 
Digested PCR products were analyzed by agarose gel electrophoresis.
The following primers were used with the corresponding restriction en-
zymes (New England Biolabs, Inc.): Ly108 all isoform (NCBI SNP accession 
no. rs31528124) primers: forward, 5-CCTACTCCCTGCAAATCAGC-3; 
and  reverse,  5-GCTCCAGCACACAAAGATGA-3  digested  with  BsrI; 
Ly108-1 and Ly108-2 isoform (NCBI SNP accession no. rs31528124) prim-
ers: forward, 5-CCTACTCCCTGCAAATCAGC-3; and reverse, 5-TGGA-
GTAAATTGTCATGGAGTCA-3 digested with BsrI; SLAM all isoform 
(NCBI  SNP  accession  no.  rs31531636)  primers:  forward,  5-GCTT-
CTTCCTTGGGGGTAAC-3; and reverse 5-TTTTTCTTCCACTGGT-
GGCT-3 digested with TaqI; and CD84 all isoform (NCBI SNP accession JEM VOL. 208, April 11, 2011 
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coated overnight with dsDNA and then with total histone solutions (Sigma-
Aldrich). Samples were incubated on plates in various dilutions between 
1:600 and 1:1,200, and then plates were washed, and autoantibodies were de-
tected with anti–mouse IgG-HRPO (GE Healthcare).
Autoantibody titer was expressed as ELISA units, comparing OD values 
of samples with a standard curve prepared with serial dilutions of ANA-
positive NZM2410 serum pool. Antichromatin and anti-dsDNA titers were 
determined as for the antinucleosome levels, except for the preparation of 
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bean nuclease (New England Biolabs, Inc.)–treated dsDNA (Sigma-Aldrich). 
Anti–single-stranded DNA (ssDNA) was determined as described previously 
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ANA. Specificity of autoantibodies was determined by indirect immuno-
fluorescence using permeabilized HEp-2 cells (Antibodies Inc.). After incu-
bation with various dilutions of mouse sera, HEp-2 slides were developed with 
anti–mouse IgG F(ab)2 (Invitrogen). Quantitative analysis was performed by 
acquiring fluorescent images (AxioImager M1; Carl Zeiss) and determining 
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T cell proliferation assay. Splenic naive CD62L+ CD4+ T cells were puri-
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expression experiments in Fig. 2 A. Fig. S3 explains the genetic difference 
between haplotype 1 and haplotype 2 mouse strains, which leads to the selec-
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